Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.3 trillion and total revenue of $120.33 billion.
Market Cap
1.3T
Revenue
120.33B
Profits
-34.53B
PE Ratio
n/a
Profit Margin
-28.70%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 135.35B | -3.46% | 1,608,314 | 12.95B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 97.37B | 0.94% | 631,616 | 16.90B |
| 3 | MRNA | Moderna, Inc. | 91.45B | 3.73% | 6,646,518 | 2.23B |
| 4 | ARGX | argenx SE | 56.50B | 2.32% | 185,734 | 5.92B |
| 5 | RVMD | Revolution Medicines, Inc. | 41.69B | 3.37% | 655,136 | - |
| 6 | ONC | BeOne Medicines AG | 40.29B | -1.92% | 258,855 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 38.42B | 0.44% | 1,657,316 | 2.54B |
| 8 | GMAB | Genmab A/S | 33.49B | 0.60% | 1,937,641 | 4.13B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.20B | 1.06% | 3,771,701 | 7.53M |
| 10 | INCY | Incyte Corporation | 24.08B | -1.58% | 1,051,264 | 6.01B |
| 11 | INSM | Insmed Incorporated | 23.05B | -3.88% | 2,052,205 | 1.52B |
| 12 | BNTX | BioNTech SE | 21.83B | -0.70% | 737,682 | 2.75B |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.33B | 0.80% | 2,203,059 | 5.01B |
| 14 | EXEL | Exelixis, Inc. | 17.85B | 4.31% | 1,878,700 | 2.50B |
| 15 | ASND | Ascendis Pharma A/S | 16.39B | 0.21% | 332,999 | 1.20B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.05B | 8.11% | 986,265 | 4.72B |
| 17 | HALO | Halozyme Therapeutics, Inc. | 14.75B | 0.75% | 643,404 | 1.66B |
| 18 | BBIO | BridgeBio Pharma, Inc. | 14.54B | -0.50% | 1,399,548 | 945.54M |
| 19 | SMMT | Summit Therapeutics Inc. | 12.96B | 9.49% | 4,292,666 | - |
| 20 | TECH | Bio-Techne Corporation | 11.40B | 0.01% | 1,481,928 | 1.22B |
| 21 | KYMR | Kymera Therapeutics, Inc. | 10.88B | -0.05% | 760,880 | 102.24M |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.84B | -2.52% | 2,746,947 | 3.66B |
| 23 | PCVX | Vaxcyte, Inc. | 9.62B | 0.86% | 855,046 | - |
| 24 | CAI | Caris Life Sciences, Inc. | 9.38B | 3.46% | 1,080,365 | 989.61M |
| 25 | SYRE | Spyre Therapeutics, Inc. | 9.28B | 4.00% | 306,461 | - |
| 26 | PTGX | Protagonist Therapeutics, Inc. | 9.14B | 1.38% | 176,364 | 281.99M |
| 27 | CORT | Corcept Therapeutics Incorporated | 9.04B | 3.91% | 766,180 | 830.81M |
| 28 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.04B | -9.28% | 1,402,667 | 1.43B |
| 29 | KRYS | Krystal Biotech, Inc. | 8.93B | 1.85% | 285,600 | 470.03M |
| 30 | TWST | Twist Bioscience Corporation | 8.78B | 8.48% | 1,269,625 | 431.80M |
| 31 | IBRX | ImmunityBio, Inc. | 8.76B | 3.96% | 3,815,685 | 165.79M |
| 32 | CYTK | Cytokinetics, Incorporated | 8.75B | 1.52% | 877,635 | 67.67M |
| 33 | TGTX | TG Therapeutics, Inc. | 8.66B | 1.78% | 836,883 | 799.54M |
| 34 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.47B | 0.64% | 429,731 | 669.50M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 7.88B | 2.95% | 94,222 | 7.46M |
| 36 | ABVX | ABIVAX Société Anonyme | 7.76B | 4.43% | 477,712 | 5.33M |
| 37 | AXSM | Axsome Therapeutics, Inc. | 7.50B | 4.94% | 1,098,486 | 865.27M |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 6.76B | -1.31% | 1,890,644 | 874.09M |
| 39 | ORKA | Oruka Therapeutics, Inc. | 6.63B | 4.95% | 444,110 | - |
| 40 | LGND | Ligand Pharmaceuticals Incorporated | 6.27B | 2.15% | 85,714 | 253.83M |
| 41 | BLTE | Belite Bio, Inc | 6.19B | -0.01% | 117,804 | - |
| 42 | KOD | Kodiak Sciences Inc. | 6.17B | 0.82% | 412,518 | - |
| 43 | IMVT | Immunovant, Inc. | 6.01B | 2.36% | 456,823 | - |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.93B | -7.90% | 5,044,810 | 280.75M |
| 45 | CGON | CG Oncology, Inc. | 5.79B | 5.42% | 289,123 | 6.23M |
| 46 | PTCT | PTC Therapeutics, Inc. | 5.72B | 12.40% | 1,543,462 | 1.16B |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 5.67B | 1.78% | 357,330 | 618.07M |
| 48 | MANE | Veradermics, Incorporated | 5.60B | 3.44% | 302,609 | - |
| 49 | COGT | Cogent Biosciences, Inc. | 5.39B | 4.37% | 947,088 | - |
| 50 | SRRK | Scholar Rock Holding Corporation | 5.31B | 1.63% | 232,028 | - |
| 51 | ERAS | Erasca, Inc. | 5.11B | 4.06% | 2,009,171 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 4.84B | 0.10% | 636,301 | 25.17M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.64B | 0.91% | 203,745 | 1.90M |
| 54 | TVTX | Travere Therapeutics, Inc. | 4.50B | -3.02% | 5,796,853 | 651.03M |
| 55 | DFTX | Definium Therapeutics, Inc. | 4.48B | 2.68% | 1,019,717 | - |
| 56 | LEGN | Legend Biotech Corporation | 4.17B | 1.90% | 459,858 | 1.27B |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.11B | -0.79% | 1,124,295 | - |
| 58 | ARQT | Arcutis Biotherapeutics, Inc. | 4.03B | 2.56% | 627,186 | 463.98M |
| 59 | TNGX | Tango Therapeutics, Inc. | 4.02B | 9.44% | 1,374,196 | 53.81M |
| 60 | ABCL | AbCellera Biologics Inc. | 3.94B | 9.40% | 1,702,719 | 66.17M |
| 61 | IOVA | Iovance Biotherapeutics, Inc. | 3.93B | 8.23% | 9,176,446 | 324.97M |
| 62 | RLAY | Relay Therapeutics, Inc. | 3.87B | 2.20% | 1,408,593 | 10.35M |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.75B | 2.91% | 607,533 | 7.50M |
| 64 | PBLS | Parabilis Medicines, Inc. | 3.62B | 7.54% | 275,281 | 148.00K |
| 65 | IRON | Disc Medicine, Inc. | 3.61B | 3.52% | 387,338 | - |
| 66 | ACAD | Acadia Pharmaceuticals Inc. | 3.56B | 1.03% | 739,018 | 1.14B |
| 67 | CELC | Celcuity Inc. | 3.45B | 5.20% | 395,520 | - |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.34B | -2.27% | 1,639,258 | - |
| 69 | DYN | Dyne Therapeutics, Inc. | 3.34B | 3.29% | 1,261,812 | - |
| 70 | ELVN | Enliven Therapeutics, Inc. | 3.30B | 0.99% | 257,316 | - |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 3.13B | -2.81% | 315,819 | 606.33M |
| 72 | TLX | Telix Pharmaceuticals Limited | 3.10B | -0.11% | 117,398 | 890.79M |
| 73 | DNLI | Denali Therapeutics Inc. | 3.07B | 1.80% | 885,099 | 3.60M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 3.04B | -0.49% | 901,110 | 36.54M |
| 75 | NRIX | Nurix Therapeutics, Inc. | 2.82B | 0.60% | 996,514 | 701.94M |
| 76 | VRDN | Viridian Therapeutics, Inc. | 2.80B | -2.35% | 2,014,705 | 71.13M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.70B | 5.35% | 911,086 | 117.00M |
| 78 | ZLAB | Zai Lab Limited | 2.70B | 0.30% | 481,352 | 449.61M |
| 79 | MBX | MBX Biosciences, Inc. | 2.69B | 2.59% | 107,213 | - |
| 80 | BEAM | Beam Therapeutics Inc. | 2.65B | 2.59% | 540,134 | 146.64M |
| 81 | PHVS | Pharvaris N.V. | 2.47B | 4.77% | 287,220 | - |
| 82 | ADMA | ADMA Biologics, Inc. | 2.45B | -0.90% | 3,111,752 | 512.28M |
| 83 | NAMS | NewAmsterdam Pharma Company N.V. | 2.40B | 2.56% | 1,500,120 | 7.12M |
| 84 | IMNM | Immunome, Inc. | 2.36B | 2.09% | 647,431 | 4.02M |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.33B | 2.07% | 392,298 | 158.00K |
| 86 | BHVN | Biohaven Ltd. | 2.32B | 1.19% | 1,139,230 | - |
| 87 | XNCR | Xencor, Inc. | 2.30B | 4.21% | 646,616 | 104.97M |
| 88 | RXRX | Recursion Pharmaceuticals, Inc. | 2.28B | -0.52% | 13,238,033 | 68.23M |
| 89 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | 3.10% | 670,220 | 321.74M |
| 90 | VERA | Vera Therapeutics, Inc. | 2.22B | 1.72% | 864,299 | - |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 2.21B | 0.13% | 489,513 | 959.90M |
| 92 | PVLA | Palvella Therapeutics, Inc. | 2.18B | 3.53% | 189,004 | - |
| 93 | ZYME | Zymeworks Inc. | 2.15B | 4.52% | 842,551 | 37.13M |
| 94 | VCEL | Vericel Corporation | 2.11B | 1.90% | 245,162 | 306.30M |
| 95 | LKFT | Lakefront Biotherapeutics NV | 2.05B | 0.45% | 58,810 | 1.13B |
| 96 | SEPN | Septerna, Inc. | 2.04B | 1.23% | 157,352 | 98.88M |
| 97 | FTRE | Fortrea Holdings Inc. | 2.02B | 4.40% | 666,702 | 2.67B |
| 98 | COAG | Hemab Therapeutics Holdings, Inc. | 2.01B | 4.47% | 226,934 | - |
| 99 | MESO | Mesoblast Limited | 2.01B | 1.96% | 88,036 | 120.25M |
| 100 | TRVI | Trevi Therapeutics, Inc. | 1.97B | 1.39% | 592,548 | - |
| 101 | SRPT | Sarepta Therapeutics, Inc. | 1.96B | 1.26% | 417,492 | 1.97B |
| 102 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.96B | 4.87% | 891,431 | 208.78M |
| 103 | TRAX | First Tracks Biotherapeutics, Inc. | 1.93B | 2.20% | 208,776 | - |
| 104 | REPL | Replimune Group, Inc. | 1.90B | 2.98% | 3,172,180 | - |
| 105 | VIR | Vir Biotechnology, Inc. | 1.89B | 1.73% | 732,986 | 303.23M |
| 106 | AGIO | Agios Pharmaceuticals, Inc. | 1.88B | 5.21% | 280,314 | 98.34M |
| 107 | PGEN | Precigen, Inc. | 1.84B | - | 6,678,560 | 85.72M |
| 108 | ZBIO | Zenas BioPharma, Inc. | 1.84B | 2.19% | 185,259 | 1.00M |
| 109 | ADRX | ADARx Pharmaceuticals, Inc. | 1.83B | 3.46% | 245,781 | 6.13M |
| 110 | GENB | Generate Biomedicines, Inc. | 1.78B | 4.69% | 414,743 | 26.48M |
| 111 | SLS | SELLAS Life Sciences Group, Inc. | 1.77B | 2.51% | 3,630,853 | - |
| 112 | STOK | Stoke Therapeutics, Inc. | 1.76B | 2.30% | 805,086 | 28.21M |
| 113 | MAZE | Maze Therapeutics, Inc. | 1.74B | 6.03% | 283,655 | 20.00M |
| 114 | BRVE | Braveheart Bio, Inc. | 1.73B | 0.81% | 128,735 | - |
| 115 | ABSI | Absci Corporation | 1.72B | 3.51% | 1,561,482 | 1.56M |
| 116 | URGN | UroGen Pharma Ltd. | 1.68B | -0.12% | 698,515 | 188.73M |
| 117 | NTLA | Intellia Therapeutics, Inc. | 1.66B | 1.42% | 1,525,446 | 59.51M |
| 118 | NUVB | Nuvation Bio Inc. | 1.65B | 2.07% | 2,742,953 | 169.90M |
| 119 | RARE | Ultragenyx Pharmaceutical Inc. | 1.64B | 2.33% | 1,375,614 | 717.00M |
| 120 | QURE | uniQure N.V. | 1.64B | 2.87% | 1,017,272 | 18.67M |
| 121 | KLRA | Kailera Therapeutics, Inc. | 1.62B | 3.05% | 372,658 | - |
| 122 | NVAX | Novavax, Inc. | 1.60B | 1.57% | 2,149,929 | 413.80M |
| 123 | LYCA | Lycia Therapeutics, Inc. | 1.58B | 0.96% | 108,515 | 4.44M |
| 124 | IMCR | Immunocore Holdings plc | 1.55B | 1.12% | 104,319 | 430.78M |
| 125 | INVA | Innoviva, Inc. | 1.52B | 0.05% | 252,998 | 440.00M |
| 126 | OCUL | Ocular Therapeutix, Inc. | 1.51B | 2.15% | 854,253 | 52.06M |
| 127 | RAPP | Rapport Therapeutics, Inc. | 1.51B | 1.23% | 359,375 | 20.00M |
| 128 | KRSA | Korsana Biosciences, Inc. | 1.50B | 3.79% | 110,523 | - |
| 129 | TYRA | Tyra Biosciences, Inc. | 1.47B | -0.05% | 157,604 | - |
| 130 | NBTX | Nanobiotix S.A. | 1.46B | 1.28% | 151,637 | 13.15M |
| 131 | GPCR | Structure Therapeutics Inc. | 1.45B | -0.39% | 377,708 | - |
| 132 | ANAB | AnaptysBio, Inc. | 1.42B | 1.47% | 104,509 | 106.09M |
| 133 | MLYS | Mineralys Therapeutics, Inc. | 1.40B | 1.54% | 1,619,891 | - |
| 134 | GHRS | GH Research PLC | 1.39B | -1.27% | 324,774 | - |
| 135 | DMRA | Damora Therapeutics, Inc. | 1.37B | 2.64% | 170,593 | - |
| 136 | KARD | Kardigan, Inc. | 1.32B | -0.56% | 276,913 | - |
| 137 | TSHA | Taysha Gene Therapies, Inc. | 1.32B | 1.25% | 791,176 | 5.49M |
| 138 | LBRX | LB Pharmaceuticals Inc | 1.32B | 4.46% | 127,138 | - |
| 139 | OMER | Omeros Corporation | 1.30B | 0.50% | 329,120 | 38.42M |
| 140 | NKTR | Nektar Therapeutics | 1.28B | 1.68% | 156,515 | 54.59M |
| 141 | SNDX | Syndax Pharmaceuticals, Inc. | 1.27B | 8.78% | 3,219,539 | 289.68M |
| 142 | DRTS | Alpha Tau Medical Ltd. | 1.25B | 5.22% | 380,759 | - |
| 143 | AAPG | Ascentage Pharma Group International | 1.23B | -0.81% | 1,241 | 94.61M |
| 144 | VOR | Vor Biopharma Inc. | 1.22B | 3.53% | 518,252 | - |
| 145 | MNKD | MannKind Corporation | 1.20B | 2.47% | 1,862,669 | 393.63M |
| 146 | INBX | Inhibrx Biosciences, Inc. | 1.20B | 12.89% | 270,320 | 1.30M |
| 147 | SLN | Silence Therapeutics plc | 1.19B | 0.18% | 233,484 | 615.00K |
| 148 | SVRA | Savara Inc. | 1.19B | -1.16% | 988,966 | - |
| 149 | VSTM | Verastem, Inc. | 1.17B | 0.73% | 1,348,626 | 87.53M |
| 150 | AVLN | Avalyn Pharma Inc. | 1.17B | 3.12% | 307,170 | - |
| 151 | SGP | SpyGlass Pharma, Inc. | 1.17B | 3.72% | 101,216 | - |
| 152 | JANX | Janux Therapeutics, Inc. | 1.08B | 0.92% | 192,600 | 24.00M |
| 153 | SPTX | Seaport Therapeutics, Inc. | 1.06B | -0.75% | 181,037 | - |
| 154 | ODTX | Odyssey Therapeutics, Inc. | 1.03B | 10.19% | 206,487 | 99.00K |
| 155 | CGEM | Cullinan Therapeutics, Inc. | 1.03B | 6.70% | 364,600 | - |
| 156 | ORIC | ORIC Pharmaceuticals, Inc. | 1.02B | 8.77% | 1,321,364 | - |
| 157 | IVA | Inventiva S.A. | 998.94M | 6.40% | 2,893,285 | 2.81M |
| 158 | MLTX | MoonLake Immunotherapeutics | 990.64M | 1.48% | 469,720 | - |
| 159 | LTGO | Latigo Biotherapeutics, Inc. | 972.28M | 8.55% | 151,338 | - |
| 160 | IMTX | Immatics N.V. | 969.13M | 0.42% | 1,088,909 | 47.65M |
| 161 | CTY | City Therapeutics, Inc. | 960.55M | -7.54% | 224,408 | 14.34M |
| 162 | JBIO | Jade Biosciences, Inc. | 929.16M | 4.88% | 1,030,341 | - |
| 163 | RIGL | Rigel Pharmaceuticals, Inc. | 912.88M | -3.29% | 181,894 | 276.79M |
| 164 | MGTX | MeiraGTx Holdings plc | 904.73M | 1.07% | 201,898 | 397.50M |
| 165 | PHAR | Pharming Group N.V. | 894.47M | -0.39% | 17,314 | 386.75M |
| 166 | GLUE | Monte Rosa Therapeutics, Inc. | 893.66M | -1.46% | 602,452 | 28.73M |
| 167 | ANRO | Alto Neuroscience, Inc. | 893.15M | 2.57% | 192,751 | - |
| 168 | KURA | Kura Oncology, Inc. | 878.04M | 0.82% | 598,926 | 77.23M |
| 169 | OBX | Obsidian Therapeutics, Inc. | 833.93M | -6.44% | 349,683 | - |
| 170 | ALMS | Alumis Inc. | 833.56M | 0.94% | 1,889,918 | 7.40M |
| 171 | CRVS | Corvus Pharmaceuticals, Inc. | 831.11M | 1.86% | 408,826 | - |
| 172 | BBTX | Bambusa Therapeutics, Inc. | 826.03M | 1.34% | 153,929 | - |
| 173 | AKTS | Aktis Oncology, Inc. | 807.60M | -0.48% | 245,306 | 10.06M |
| 174 | PRME | Prime Medicine, Inc. | 797.90M | 1.01% | 2,608,710 | 4.07M |
| 175 | ANNX | Annexon, Inc. | 785.81M | 5.20% | 2,629,461 | - |
| 176 | ABUS | Arbutus Biopharma Corporation | 776.55M | -1.88% | 1,141,143 | 181.72M |
| 177 | ARDX | Ardelyx, Inc. | 758.78M | 0.50% | 2,824,824 | 450.89M |
| 178 | OABI | OmniAb, Inc. | 739.51M | -0.39% | 942,268 | 40.21M |
| 179 | SLBT | SL Science Holding Limited | 721.39M | -0.39% | 5,940 | 3.27M |
| 180 | SANA | Sana Biotechnology, Inc. | 719.96M | 0.21% | 1,012,580 | - |
| 181 | WVE | Wave Life Sciences, Inc. | 708.05M | 1.99% | 1,416,295 | 70.92M |
| 182 | DBVT | DBV Technologies S.A. | 702.78M | 11.82% | 217,016 | 3.74M |
| 183 | SGMT | Sagimet Biosciences Inc. | 702.70M | 2.27% | 326,350 | - |
| 184 | DNA | Ginkgo Bioworks Holdings, Inc. | 698.99M | 5.38% | 1,312,292 | 132.42M |
| 185 | ACHV | Achieve Life Sciences, Inc. | 695.11M | 2.19% | 445,921 | - |
| 186 | ATTO | Attovia Therapeutics, Inc. | 694.13M | 1.03% | 64,086 | 1.80M |
| 187 | CADL | Candel Therapeutics, Inc. | 673.36M | 8.37% | 2,139,288 | - |
| 188 | HELP | Helus Pharma Inc. | 661.93M | 2.95% | 863,091 | - |
| 189 | SLDB | Solid Biosciences Inc. | 659.44M | 2.50% | 365,700 | - |
| 190 | FDMT | 4D Molecular Therapeutics, Inc. | 653.54M | 4.05% | 376,589 | 92.01M |
| 191 | AVBP | ArriVent BioPharma, Inc. | 653.08M | -0.79% | 601,371 | - |
| 192 | LXRX | Lexicon Pharmaceuticals, Inc. | 651.86M | 1.74% | 438,769 | 41.47M |
| 193 | DSGN | Design Therapeutics, Inc. | 647.09M | 1.87% | 75,645 | - |
| 194 | OLMA | Olema Pharmaceuticals, Inc. | 645.73M | 4.38% | 643,890 | - |
| 195 | AURA | Aura Biosciences, Inc. | 644.01M | 2.99% | 325,249 | - |
| 196 | APMD | Apnimed, Inc. | 643.61M | 0.39% | 438,421 | 115.12M |
| 197 | IAM | Iambic Therapeutics, Inc. | 634.70M | 3.36% | 174,373 | 18.25M |
| 198 | IMMX | Immix Biopharma, Inc. | 627.58M | 4.27% | 546,217 | - |
| 199 | NVCT | Nuvectis Pharma, Inc. | 620.68M | -0.68% | 49,075 | - |
| 200 | ANL | Adlai Nortye Group Ltd. | 618.22M | 2.45% | 194,822 | 18.06M |
| 201 | BCAX | Bicara Therapeutics Inc. | 614.08M | 17.02% | 1,502,599 | - |
| 202 | ZVRA | Zevra Therapeutics, Inc. | 610.47M | 1.78% | 310,566 | 136.07M |
| 203 | GERN | Geron Corporation | 600.07M | 0.53% | 4,243,465 | 204.56M |
| 204 | ACRS | Aclaris Therapeutics, Inc. | 572.67M | -2.76% | 970,470 | 8.22M |
| 205 | CBIO | Crescent Biopharma, Inc. | 562.41M | 1.78% | 58,550 | 11.88M |
| 206 | CLYM | Climb Bio, Inc. | 554.55M | -0.87% | 255,002 | - |
| 207 | VALN | Valneva SE | 551.18M | 4.70% | 3,468 | 163.30M |
| 208 | STTK | Shattuck Labs, Inc. | 545.98M | 2.26% | 251,051 | 1.00M |
| 209 | NGNE | Neurogene Inc. | 533.50M | 0.19% | 101,150 | 925.00K |
| 210 | PBYI | Puma Biotechnology, Inc. | 528.07M | 0.49% | 238,096 | 231.24M |
| 211 | DMAC | DiaMedica Therapeutics Inc. | 527.93M | 5.38% | 83,158 | - |
| 212 | ENTX | Entera Bio Ltd. | 526.98M | -1.94% | 84,373 | 42.00K |
| 213 | SRZN | Surrozen, Inc. | 521.18M | 2.65% | 56,548 | 11.51M |
| 214 | FTH | Faeth Therapeutics, Inc. | 512.42M | 3.12% | 122,373 | - |
| 215 | INDP | Indaptus Therapeutics, Inc. | 505.28M | -6.00% | 85,511 | - |
| 216 | ETRA | Electra Therapeutics, Inc. | 501.51M | 9.30% | 468,431 | - |
| 217 | RGNX | REGENXBIO Inc. | 497.08M | 5.17% | 450,478 | 174.48M |
| 218 | CTMX | CytomX Therapeutics, Inc. | 478.29M | -1.57% | 2,274,902 | 18.30M |
| 219 | GYRE | Gyre Therapeutics, Inc. | 475.03M | -5.29% | 174,604 | 109.82M |
| 220 | OVID | Ovid Therapeutics Inc. | 469.69M | 0.63% | 745,375 | 1.58M |
| 221 | MDXG | MiMedx Group, Inc. | 464.77M | -2.90% | 762,797 | 303.73M |
| 222 | MNPR | Monopar Therapeutics Inc. | 464.21M | 4.35% | 88,379 | - |
| 223 | OCS | Oculis Holding AG | 458.05M | -3.76% | 263,674 | 1.45M |
| 224 | EPRX | Eupraxia Pharmaceuticals Inc. | 450.14M | 1.85% | 374,106 | - |
| 225 | RLMD | Relmada Therapeutics, Inc. | 449.61M | 9.77% | 1,121,323 | - |
| 226 | ARVN | Arvinas, Inc. | 447.90M | -8.91% | 795,070 | 275.30M |
| 227 | PHAT | Phathom Pharmaceuticals, Inc. | 444.01M | -5.49% | 1,096,254 | 274.88M |
| 228 | YDES | YD Bio Limited | 443.40M | 4.86% | 16,476 | 1.24M |
| 229 | CAPR | Capricor Therapeutics, Inc. | 434.30M | 3.18% | 1,915,543 | 11.13M |
| 230 | CRMD | CorMedix Inc. | 432.59M | 2.97% | 1,533,479 | 462.25M |
| 231 | RZLT | Rezolute, Inc. | 420.64M | 3.35% | 541,346 | - |
| 232 | PRTA | Prothena Corporation plc | 419.94M | -1.33% | 104,224 | 54.53M |
| 233 | ASMB | Assembly Biosciences, Inc. | 401.10M | 0.97% | 69,470 | 74.85M |
| 234 | ALT | Altimmune, Inc. | 398.76M | 1.49% | 1,067,019 | 31.00K |
| 235 | EDIT | Editas Medicine, Inc. | 397.00M | 0.58% | 1,063,181 | 47.01M |
| 236 | BLSM | BlossomHill Therapeutics, Inc. | 396.52M | 0.44% | 71,172 | - |
| 237 | CCCC | C4 Therapeutics, Inc. | 394.91M | - | 1,122,746 | 35.04M |
| 238 | PRLD | Prelude Therapeutics Incorporated | 390.35M | -1.30% | 92,274 | 22.42M |
| 239 | ALLO | Allogene Therapeutics, Inc. | 384.43M | 2.08% | 14,485,009 | 4.64M |
| 240 | AVTX | Avalo Therapeutics, Inc. | 383.99M | -2.19% | 1,147,654 | 59.00K |
| 241 | MPLT | MapLight Therapeutics, Inc. | 383.75M | 1.84% | 186,218 | - |
| 242 | ZURA | Zura Bio Limited | 383.38M | 1.02% | 1,298,170 | - |
| 243 | FENC | Fennec Pharmaceuticals Inc. | 374.87M | 1.42% | 88,683 | 59.22M |
| 244 | AUTL | Autolus Therapeutics plc | 372.63M | -1.41% | 2,031,770 | 117.39M |
| 245 | TRXB | TRex Bio, Inc. | 370.72M | 0.95% | 91,588 | - |
| 246 | TECX | Tectonic Therapeutic, Inc. | 369.58M | -0.40% | 87,272 | - |
| 247 | CTNM | Contineum Therapeutics, Inc. | 360.41M | 0.21% | 299,514 | - |
| 248 | ASPE | Aspen Neuroscience, Inc. | 357.09M | -5.83% | 307,940 | - |
| 249 | GALT | Galectin Therapeutics Inc. | 338.85M | 0.90% | 63,254 | - |
| 250 | AVIR | Atea Pharmaceuticals, Inc. | 338.46M | 2.93% | 193,504 | - |
| 251 | OBIO | Orchestra BioMed Holdings, Inc. | 337.19M | -1.41% | 107,849 | 31.98M |
| 252 | AGMB | AgomAb Therapeutics NV | 332.92M | 0.60% | 28,286 | - |
| 253 | IRD | Opus Genetics, Inc. | 330.29M | 7.30% | 574,666 | 9.86M |
| 254 | XFOR | X4 Pharmaceuticals, Inc. | 324.71M | -2.24% | 204,035 | 15.85M |
| 255 | PROK | ProKidney Corp. | 323.49M | -4.46% | 1,227,321 | 818.00K |
| 256 | KYTX | Kyverna Therapeutics, Inc. | 317.26M | -1.72% | 486,911 | - |
| 257 | ENTA | Enanta Pharmaceuticals, Inc. | 307.27M | 1.15% | 146,690 | 65.26M |
| 258 | ALEC | Alector, Inc. | 303.93M | -4.65% | 1,100,062 | 13.86M |
| 259 | AGEN | Agenus Inc. | 302.09M | 2.76% | 314,058 | 132.69M |
| 260 | NAUT | Nautilus Biotechnology, Inc. | 301.87M | 1.50% | 3,511,222 | 424.00K |
| 261 | SCTX | Scribe Therapeutics Inc. | 301.20M | 2.38% | 164,944 | 33.30M |
| 262 | EIKN | Eikon Therapeutics, Inc. | 300.35M | -2.38% | 340,862 | - |
| 263 | VOGX | Vogenx, Inc. | 300.00M | -2.63% | 60,172 | - |
| 264 | VTVT | vTv Therapeutics Inc. | 292.79M | -2.42% | 27,912 | 36.84M |
| 265 | SPRY | ARS Pharmaceuticals, Inc. | 291.38M | -3.93% | 1,275,036 | 116.93M |
| 266 | BNTC | Benitec Biopharma Inc. | 291.27M | -1.65% | 48,559 | - |
| 267 | FULC | Fulcrum Therapeutics, Inc. | 285.73M | 2.60% | 853,457 | 80.00M |
| 268 | SABS | SAB Biotherapeutics, Inc. | 285.70M | -4.85% | 164,818 | 114.70K |
| 269 | TTRX | Turn Therapeutics Inc. | 281.79M | -1.97% | 76,449 | - |
| 270 | IPSC | Century Therapeutics, Inc. | 277.05M | 3.38% | 545,753 | 109.16M |
| 271 | IKT | Inhibikase Therapeutics, Inc. | 270.38M | -3.57% | 297,993 | 1.00 |
| 272 | RCKT | Rocket Pharmaceuticals, Inc. | 267.85M | -1.21% | 836,541 | - |
| 273 | VCRE | Vicore Pharma Holding AB (publ) | 267.61M | -2.09% | 10,976 | 412.09K |
| 274 | LYEL | Lyell Immunopharma, Inc. | 265.39M | -0.46% | 41,051 | 27.00K |
| 275 | QTTB | Q32 Bio Inc. | 262.33M | 1.17% | 99,742 | 53.74M |
| 276 | LRMR | Larimar Therapeutics, Inc. | 261.48M | 5.70% | 1,051,407 | - |
| 277 | ARCT | Arcturus Therapeutics Holdings Inc. | 261.21M | -3.16% | 551,347 | 29.37M |
| 278 | BCYC | Bicycle Therapeutics plc | 255.84M | 0.83% | 50,180 | 83.53M |
| 279 | LCTX | Lineage Cell Therapeutics, Inc. | 255.44M | - | 395,562 | 13.08M |
| 280 | LXEO | Lexeo Therapeutics, Inc. | 254.74M | 1.47% | 840,249 | - |
| 281 | CUVL | Clinuvel Pharmaceuticals Limited | 254.29M | 1.93% | 549 | 65.05M |
| 282 | OCGN | Ocugen, Inc. | 250.84M | 2.07% | 2,952,599 | 4.58M |
| 283 | ABEO | Abeona Therapeutics Inc. | 242.46M | -0.24% | 474,863 | 25.52M |
| 284 | FATE | Fate Therapeutics, Inc. | 241.44M | 0.25% | 475,022 | 6.49M |
| 285 | IFRX | InflaRx N.V. | 240.95M | -7.37% | 5,015,492 | -11.54K |
| 286 | IMRX | Immuneering Corporation | 240.92M | 6.59% | 574,916 | - |
| 287 | CAMP | Camp4 Therapeutics Corporation | 240.34M | 1.46% | 75,048 | 4.22M |
| 288 | CABA | Cabaletta Bio, Inc. | 239.91M | -1.05% | 1,892,672 | - |
| 289 | GLSI | Greenwich LifeSciences, Inc. | 236.76M | -2.00% | 35,533 | - |
| 290 | KRRO | Korro Bio, Inc. | 234.14M | 0.35% | 310,975 | 2.38M |
| 291 | VNDA | Vanda Pharmaceuticals Inc. | 223.13M | -4.90% | 963,773 | 229.28M |
| 292 | DRUG | Bright Minds Biosciences Inc. | 220.56M | -15.52% | 694,039 | - |
| 293 | KROS | Keros Therapeutics, Inc. | 217.11M | 1.77% | 51,750 | 15.01M |
| 294 | SLGL | Sol-Gel Technologies Ltd. | 215.09M | 0.01% | 25,468 | 1.80M |
| 295 | PALI | Palisade Bio, Inc. | 213.48M | 9.37% | 1,939,231 | 500.00K |
| 296 | EVMN | Evommune, Inc. | 213.03M | -2.33% | 133,849 | 10.00M |
| 297 | ELDN | Eledon Pharmaceuticals, Inc. | 211.89M | -0.57% | 204,498 | - |
| 298 | ACIU | AC Immune SA | 211.28M | 3.16% | 83,103 | 21.67M |
| 299 | ARTV | Artiva Biotherapeutics, Inc. | 204.85M | - | 348,050 | 251.00K |
| 300 | PLX | Protalix BioTherapeutics, Inc. | 203.85M | -1.17% | 112,424 | 80.62M |
| 301 | PYXS | Pyxis Oncology, Inc. | 196.51M | -2.66% | 454,076 | 11.04M |
| 302 | RNAC | Cartesian Therapeutics, Inc. | 195.15M | 1.74% | 52,643 | 1.48M |
| 303 | DTIL | Precision BioSciences, Inc. | 191.69M | -0.07% | 67,832 | 45.04M |
| 304 | CGEN | Compugen Ltd. | 191.34M | 2.02% | 76,067 | 74.00M |
| 305 | PRQR | ProQR Therapeutics N.V. | 189.10M | 1.52% | 535,212 | 21.05M |
| 306 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 186.41M | 0.65% | 340,145 | - |
| 307 | UPB | Upstream Bio, Inc. | 184.58M | 0.60% | 515,887 | 3.16M |
| 308 | ACOG | Alpha Cognition Inc. | 179.34M | -1.26% | 92,442 | 15.26M |
| 309 | ALXO | ALX Oncology Holdings Inc. | 178.38M | -5.84% | 415,543 | - |
| 310 | INO | Inovio Pharmaceuticals, Inc. | 176.29M | -9.79% | 38,031,718 | 65.34K |
| 311 | WHWK | Whitehawk Therapeutics, Inc. | 176.16M | -0.96% | 115,889 | 7.15M |
| 312 | MDWD | MediWound Ltd. | 173.13M | -0.67% | 53,480 | 11.86M |
| 313 | IVVD | Invivyd, Inc. | 169.55M | -1.17% | 2,542,432 | 58.37M |
| 314 | TRDA | Entrada Therapeutics, Inc. | 168.75M | -8.41% | 260,035 | 4.69M |
| 315 | PEPG | PepGen Inc. | 167.95M | 3.19% | 368,841 | - |
| 316 | ZNTL | Zentalis Pharmaceuticals, Inc. | 167.57M | -4.32% | 724,064 | 26.87M |
| 317 | ORMP | Oramed Pharmaceuticals Inc. | 164.31M | -1.25% | 44,891 | 2.00M |
| 318 | SION | Sionna Therapeutics, Inc. | 161.86M | -4.02% | 568,202 | - |
| 319 | ADAG | Adagene Inc. | 161.14M | 4.80% | 80,645 | 9.29M |
| 320 | STRO | Sutro Biopharma, Inc. | 159.35M | 5.49% | 71,188 | 45.70M |
| 321 | YARW | Yarrow Bioscience, Inc. | 157.62M | -5.52% | 170,800 | - |
| 322 | ANTX | AN2 Therapeutics, Inc. | 155.66M | -5.17% | 70,722 | - |
| 323 | CNTN | Canton Strategic Holdings, Inc. | 155.38M | -4.41% | 252,169 | 1.50M |
| 324 | RNA | Atrium Therapeutics, Inc. | 148.90M | 1.81% | 176,750 | 35.84M |
| 325 | MGNX | MacroGenics, Inc. | 148.42M | - | 252,835 | 175.14M |
| 326 | TARA | Protara Therapeutics, Inc. | 144.49M | 1.45% | 153,168 | - |
| 327 | CUE | Cue Biopharma, Inc. | 143.94M | 2.03% | 134,675 | 37.66M |
| 328 | VRXA | Veraxa Biotech AG | 139.99M | -3.88% | 50,727 | 29.54K |
| 329 | NGEN | NervGen Pharma Corp. | 139.24M | -4.07% | 294,122 | - |
| 330 | MSLE | Satellos Bioscience Inc. | 138.81M | 1.02% | 11,558 | - |
| 331 | CMPX | Compass Therapeutics, Inc. | 134.87M | -2.42% | 951,265 | 850.00K |
| 332 | MENS | Jyong Biotech Ltd. | 129.91M | -6.42% | 82,012 | - |
| 333 | FHTX | Foghorn Therapeutics Inc. | 125.30M | -0.94% | 389,179 | 36.74M |
| 334 | SPRB | Spruce Biosciences, Inc. | 124.04M | -3.12% | 48,811 | 697.00K |
| 335 | CHRS | Coherus Oncology, Inc. | 123.61M | 6.76% | 1,507,816 | 50.94M |
| 336 | MOLN | Molecular Partners AG | 121.20M | -6.76% | 1,713 | 856.30K |
| 337 | IPHA | Innate Pharma S.A. | 119.86M | -4.29% | 67,535 | 11.21M |
| 338 | HUMA | Humacyte, Inc. | 119.29M | 7.86% | 2,193,397 | 2.12M |
| 339 | NBP | NovaBridge Biosciences | 118.32M | -4.67% | 294,585 | - |
| 340 | CDXS | Codexis, Inc. | 116.62M | 1.91% | 323,416 | 77.68M |
| 341 | AVXL | Anavex Life Sciences Corp. | 112.16M | 6.14% | 512,924 | - |
| 342 | KZIA | Kazia Therapeutics Limited | 111.82M | 1.75% | 84,817 | 1.27M |
| 343 | OTLK | Outlook Therapeutics, Inc. | 111.82M | -2.11% | 1,818,525 | -1.16M |
| 344 | NMRA | Neumora Therapeutics, Inc. | 111.78M | 20.01% | 4,379,630 | - |
| 345 | NERV | Minerva Neurosciences, Inc. | 111.73M | -0.21% | 148,949 | - |
| 346 | PYPD | PolyPid Ltd. | 111.71M | 1.48% | 86,207 | - |
| 347 | VYGR | Voyager Therapeutics, Inc. | 111.53M | 1.69% | 493,081 | 34.46M |
| 348 | LENZ | LENZ Therapeutics, Inc. | 110.60M | 15.41% | 1,064,089 | 12.36M |
| 349 | NKTX | Nkarta, Inc. | 110.30M | 1.32% | 455,787 | - |
| 350 | PDSB | PDS Biotechnology Corporation | 109.80M | 10.58% | 4,063,945 | - |
| 351 | HURA | TuHURA Biosciences, Inc. | 109.29M | -0.29% | 366,136 | - |
| 352 | EQ | Equillium, Inc. | 108.93M | 0.72% | 101,986 | 4.39M |
| 353 | ARMP | Armata Pharmaceuticals, Inc. | 108.57M | 2.46% | 18,190 | 5.54M |
| 354 | ANIX | Anixa Biosciences, Inc. | 106.03M | 2.01% | 97,499 | - |
| 355 | TENX | Tenax Therapeutics, Inc. | 104.83M | 1.67% | 1,841,586 | - |
| 356 | PMVP | PMV Pharmaceuticals, Inc. | 104.21M | 0.73% | 389,224 | - |
| 357 | MIST | Milestone Pharmaceuticals Inc. | 103.85M | 2.20% | 400,331 | 2.34M |
| 358 | IMUX | Immunic, Inc. | 103.02M | 2.86% | 115,940 | - |
| 359 | BDTX | Black Diamond Therapeutics, Inc. | 102.84M | 2.29% | 207,926 | 70.00M |
| 360 | ENGN | enGene Therapeutics Inc. | 101.86M | 4.83% | 566,394 | - |
| 361 | NRXP | NRx Pharmaceuticals, Inc. | 100.80M | 7.37% | 1,357,519 | 3.39M |
| 362 | OKUR | OnKure Therapeutics, Inc. | 100.63M | -4.05% | 101,691 | - |
| 363 | RTSN | Retension Pharmaceuticals, Inc. | 100.40M | 6.64% | 60,978 | - |
| 364 | UNCY | Unicycive Therapeutics, Inc. | 98.89M | 1.72% | 712,126 | - |
| 365 | VANI | Vivani Medical, Inc. | 95.62M | -2.75% | 178,089 | - |
| 366 | SEER | Seer, Inc. | 95.52M | -0.29% | 92,536 | 14.22M |
| 367 | ICCC | ImmuCell Corporation | 94.73M | -1.23% | 4,389 | 30.68M |
| 368 | TVGN | Tevogen Inc. | 94.26M | 7.16% | 3,539 | - |
| 369 | TNXP | Tonix Pharmaceuticals Holding Corp. | 89.19M | 0.97% | 317,059 | 29.10M |
| 370 | GNLX | Genelux Corporation | 87.16M | -2.75% | 170,513 | 8.00K |
| 371 | RLYB | Rallybio Corporation | 87.06M | 2.60% | 33,225 | 434.00K |
| 372 | PLYX | Polaryx Therapeutics, Inc. | 86.73M | -0.57% | 15,055 | - |
| 373 | CBUS | Cibus, Inc. | 86.36M | -8.87% | 70,291 | 4.35M |
| 374 | TLSA | Tiziana Life Sciences Ltd | 86.21M | 0.51% | 378,883 | - |
| 375 | NRXS | NeurAxis, Inc. | 84.26M | 1.67% | 114,012 | 5.32M |
| 376 | ATRA | Atara Biotherapeutics, Inc. | 82.81M | -2.71% | 12,607 | 6.19M |
| 377 | TNYA | Tenaya Therapeutics, Inc. | 82.60M | 2.04% | 1,314,012 | 1.34M |
| 378 | CLLS | Cellectis S.A. | 80.18M | 0.48% | 20,435 | 63.82M |
| 379 | NTRB | Nutriband Inc. | 78.22M | 0.39% | 11,781 | 1.62M |
| 380 | RANI | Rani Therapeutics Holdings, Inc. | 77.56M | 0.83% | 497,291 | 4.88M |
| 381 | NTHI | NeOnc Technologies Holdings, Inc. | 77.06M | 0.98% | 32,322 | 39.99K |
| 382 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 76.30M | 0.77% | 3,631,067 | - |
| 383 | OKYO | OKYO Pharma Limited | 75.57M | -1.37% | 9,472 | - |
| 384 | COYA | Coya Therapeutics, Inc. | 72.25M | -4.64% | 433,874 | 8.02M |
| 385 | ACRV | Acrivon Therapeutics, Inc. | 71.14M | 3.11% | 91,104 | - |
| 386 | MNOV | MediciNova, Inc. | 69.89M | -1.39% | 30,531 | 920.48K |
| 387 | CNXU | Conexeu Sciences Inc. | 69.37M | -6.25% | 165,085 | - |
| 388 | CSBR | Champions Oncology, Inc. | 68.76M | 2.70% | 5,426 | 60.66M |
| 389 | TELO | Telomir Pharmaceuticals, Inc. | 67.98M | 0.90% | 22,110 | - |
| 390 | CING | Cingulate Inc. | 67.91M | -7.16% | 141,818 | - |
| 391 | MAIA | MAIA Biotechnology, Inc. | 67.21M | 0.45% | 99,592 | - |
| 392 | CRDF | Cardiff Oncology, Inc. | 66.37M | 1.05% | 143,010 | 508.00K |
| 393 | CGTX | Cognition Therapeutics, Inc. | 65.74M | -2.58% | 268,655 | - |
| 394 | FBIO | Fortress Biotech, Inc. | 64.53M | 0.26% | 48,913 | 68.47M |
| 395 | XBIT | XBiotech Inc. | 61.59M | 5.21% | 60,329 | - |
| 396 | SPRO | Spero Therapeutics, Inc. | 60.86M | 0.48% | 168,480 | 47.00M |
| 397 | RNXT | RenovoRx, Inc. | 57.77M | 1.59% | 207,947 | 1.98M |
| 398 | RNTX | Rein Therapeutics Inc. | 57.73M | 5.32% | 178,800 | - |
| 399 | INKT | MiNK Therapeutics, Inc. | 57.49M | 2.04% | 6,149 | - |
| 400 | VRCA | Verrica Pharmaceuticals Inc. | 56.17M | 1.87% | 35,646 | 30.32M |
| 401 | XLO | Xilio Therapeutics, Inc. | 55.93M | 6.38% | 19,805 | 64.09M |
| 402 | GOSS | Gossamer Bio, Inc. | 55.11M | -4.66% | 77,611 | 53.29M |
| 403 | BOLD | Boundless Bio, Inc. | 54.59M | -1.64% | 24,595 | - |
| 404 | HRTX | Heron Therapeutics, Inc. | 53.92M | -3.76% | 601,145 | 151.18M |
| 405 | CLNN | Clene Inc. | 53.44M | 4.16% | 28,891 | 197.00K |
| 406 | OSTX | OS Therapies Incorporated | 53.37M | 0.43% | 305,694 | - |
| 407 | ELOX | Eloxx Pharmaceuticals, Inc. | 52.47M | 1.25% | 20,147 | - |
| 408 | ALPS | Alps Group Inc | 52.40M | -2.90% | 48,836 | 3.74M |
| 409 | PLRX | Pliant Therapeutics, Inc. | 52.38M | 0.80% | 66,695 | - |
| 410 | IBIO | iBio, Inc. | 52.09M | 1.26% | 159,732 | 100.00K |
| 411 | HOWL | Werewolf Therapeutics, Inc. | 51.76M | 1.43% | 147,715 | 21.00M |
| 412 | HYFT | MindWalk Holdings Corp. | 50.41M | -2.73% | 164,157 | 11.57M |
| 413 | GANX | Gain Therapeutics, Inc. | 50.19M | 1.77% | 158,870 | - |
| 414 | KLRS | Kalaris Therapeutics, Inc. | 49.99M | 5.00% | 7,997 | - |
| 415 | ONCY | Oncolytics Biotech Inc. | 48.67M | -4.58% | 431,500 | - |
| 416 | CNTB | Connect Biopharma Holdings Limited | 48.40M | -1.11% | 69,814 | 2.95M |
| 417 | BMEA | Biomea Fusion, Inc. | 47.80M | -0.06% | 588,971 | - |
| 418 | ANVS | Annovis Bio, Inc. | 47.72M | 3.70% | 483,115 | - |
| 419 | CRBU | Caribou Biosciences, Inc. | 47.54M | 0.80% | 706,580 | 10.04M |
| 420 | HYPD | Hyperion DeFi, Inc. | 47.47M | 2.86% | 53,086 | 1.40M |
| 421 | MREO | Mereo BioPharma Group plc | 46.34M | 0.07% | 204,317 | 500.00K |
| 422 | IMA | ImageneBio, Inc. | 46.31M | -0.24% | 5,663 | 800.00K |
| 423 | LONA | LeonaBio, Inc. | 46.17M | 3.59% | 15,059 | - |
| 424 | APLM | Apollomics, Inc. | 45.90M | 0.29% | 1,668 | 8.84M |
| 425 | ATNM | Actinium Pharmaceuticals, Inc. | 45.59M | 1.40% | 45,171 | 35.09M |
| 426 | TIL | Instil Bio, Inc. | 45.10M | 1.53% | 13,570 | - |
| 427 | ATHE | Alterity Therapeutics Limited | 44.67M | 15.79% | 3,835,319 | 2.50M |
| 428 | EXOZ | eXoZymes, Inc. | 44.27M | 5.53% | 1,807 | -700.00 |
| 429 | SER | Serina Therapeutics, Inc. | 42.16M | -10.27% | 21,125 | 130.00K |
| 430 | PTHS | Pelthos Therapeutics Inc. | 41.86M | -5.08% | 29,105 | 43.30M |
| 431 | INMB | INmune Bio Inc. | 40.60M | -4.35% | 155,842 | 50.00K |
| 432 | ELTX | Elicio Therapeutics, Inc. | 38.90M | -6.92% | 343,206 | - |
| 433 | GRCE | Grace Therapeutics, Inc. | 38.08M | - | 181,449 | - |
| 434 | ALDX | Aldeyra Therapeutics, Inc. | 37.36M | 6.19% | 421,159 | - |
| 435 | NNVC | NanoViricides, Inc. | 36.43M | 5.71% | 124,926 | - |
| 436 | VERU | Veru Inc. | 35.99M | -2.27% | 38,846 | 16.89M |
| 437 | IBO | Impact BioMedical Inc. | 34.77M | 1.50% | 13,535 | 35.00K |
| 438 | ACET | Adicet Bio, Inc. | 34.45M | - | 55,154 | - |
| 439 | EYPT | EyePoint, Inc. | 33.59M | 3.96% | 2,126,440 | 2.79M |
| 440 | GRDX | GridAI Technologies Corp. | 33.07M | -2.51% | 69,444 | - |
| 441 | IRLA | IRulya Therapeutics Inc. | 32.59M | -4.50% | 32,960 | - |
| 442 | DWTX | Dogwood Therapeutics, Inc. | 32.13M | -22.53% | 341,544 | - |
| 443 | LITS | Lite Strategy, Inc. | 31.93M | 8.50% | 157,921 | - |
| 444 | EDSA | Edesa Biotech, Inc. | 30.67M | -6.97% | 38,040 | - |
| 445 | PMN | ProMIS Neurosciences, Inc. | 30.31M | 12.67% | 551,718 | - |
| 446 | ALGS | Aligos Therapeutics, Inc. | 30.10M | 4.78% | 7,585 | 31.52M |
| 447 | MGX | Metagenomi Therapeutics, Inc. | 29.04M | 1.81% | 26,294 | 13.56M |
| 448 | FLNA | Filana Therapeutics, Inc. | 27.79M | 2.53% | 211,920 | - |
| 449 | PLRZ | Polyrizon Ltd. | 27.08M | -0.98% | 20,780 | - |
| 450 | AARD | Aardvark Therapeutics, Inc. | 27.03M | 2.92% | 119,774 | - |
| 451 | NXTC | NextCure, Inc. | 26.69M | 2.37% | 22,920 | - |
| 452 | BCTX | BriaCell Therapeutics Corp. | 26.33M | -1.43% | 33,295 | - |
| 453 | RNAZ | TransCode Therapeutics, Inc. | 26.24M | -4.91% | 24,042 | - |
| 454 | CELU | Celularity Inc. | 26.13M | 0.34% | 39,138 | 18.67M |
| 455 | ABVC | ABVC BioPharma, Inc. | 25.95M | 1.98% | 13,877 | 797.92K |
| 456 | BYSI | BeyondSpring Inc. | 25.49M | -23.07% | 216,346 | 1.88M |
| 457 | EVAX | Evaxion A/S | 24.65M | 1.20% | 22,895 | 7.49M |
| 458 | CVM | CEL-SCI Corporation | 24.54M | 6.49% | 182,240 | - |
| 459 | CRVO | CervoMed Inc. | 23.59M | -4.88% | 265,136 | 331.30K |
| 460 | ATOS | Atossa Therapeutics, Inc. | 23.25M | 1.30% | 12,439 | - |
| 461 | COCP | Cocrystal Pharma, Inc. | 21.19M | 3.77% | 19,984 | 330.00K |
| 462 | IMMP | Immutep Limited | 21.15M | -2.61% | 10,623 | 13.79M |
| 463 | IGC | IGC Pharma, Inc. | 19.90M | -0.21% | 250,132 | 1.11M |
| 464 | BSEM | BioStem Technologies, Inc. | 19.70M | -8.62% | 261,541 | 34.59M |
| 465 | ACTU | Actuate Therapeutics, Inc. | 19.38M | 3.04% | 148,379 | - |
| 466 | QNTM | Quantum BioPharma Ltd. | 19.21M | 0.38% | 35,710 | - |
| 467 | QNRX | Quoin Pharmaceuticals, Ltd. | 18.93M | -1.99% | 19,596 | - |
| 468 | MCRB | Seres Therapeutics, Inc. | 18.88M | 2.73% | 26,820 | 1.88M |
| 469 | AKTX | Akari Therapeutics, Plc | 18.33M | 2.30% | 57,943 | - |
| 470 | CNTX | Context Therapeutics Inc. | 18.03M | -2.87% | 552,828 | - |
| 471 | ALLR | Allarity Therapeutics, Inc. | 17.82M | 14.55% | 249,299 | 345.00K |
| 472 | KYNB | Kyntra Bio, Inc. | 17.21M | -4.71% | 14,641 | 4.62M |
| 473 | BOLT | Bolt Biotherapeutics, Inc. | 16.75M | 3.85% | 19,940 | 4.70M |
| 474 | MRKR | Marker Therapeutics, Inc. | 16.60M | 10.49% | 84,112 | 3.55M |
| 475 | ABOS | Acumen Pharmaceuticals, Inc. | 16.60M | -4.26% | 5,009,680 | - |
| 476 | JSPR | Jasper Therapeutics, Inc. | 16.35M | -3.25% | 123,944 | - |
| 477 | NEUP | Neuphoria Therapeutics Inc. | 16.34M | -0.66% | 3,517 | 1.17M |
| 478 | KTTA | Pasithea Therapeutics Corp. | 16.33M | 32.80% | 16,144,532 | - |
| 479 | ATYR | aTyr Pharma, Inc. | 15.33M | -0.64% | 181,024 | 190.00K |
| 480 | ESLA | Estrella Immunopharma, Inc. | 15.30M | -17.50% | 262,481 | - |
| 481 | PLUR | Pluri Inc. | 15.07M | 1.73% | 33,983 | 1.02M |
| 482 | CTXR | Citius Pharmaceuticals, Inc. | 15.04M | -2.53% | 23,770 | 7.11M |
| 483 | NCEL | NewcelX Ltd. | 14.44M | 0.40% | 18,702 | - |
| 484 | BCDA | BioCardia, Inc. | 13.87M | 1.60% | 61,983 | 3.00K |
| 485 | DYAI | Dyadic International, Inc. | 13.15M | -3.99% | 22,032 | 3.80M |
| 486 | BIVI | BioVie Inc. | 13.12M | 27.01% | 12,592,232 | - |
| 487 | TCRX | TScan Therapeutics, Inc. | 12.80M | 5.36% | 179,047 | 7.11M |
| 488 | HIND | Vyome Holdings, Inc. | 12.56M | 1.70% | 2,305 | 129.73K |
| 489 | PBM | Psyence Biomedical Ltd. | 12.55M | 3.46% | 33,137 | - |
| 490 | DARE | Daré Bioscience, Inc. | 12.51M | -2.90% | 95,243 | 1.37M |
| 491 | CLRB | Cellectar Biosciences, Inc. | 12.29M | 6.56% | 89,785 | - |
| 492 | GUTS | Fractyl Health, Inc. | 11.96M | -4.35% | 130,662 | 3.00K |
| 493 | LPCN | Lipocine Inc. | 11.95M | - | 97,569 | 1.57M |
| 494 | AEON | AEON Biopharma, Inc. | 11.32M | -16.89% | 731,524 | - |
| 495 | PASG | Passage Bio, Inc. | 11.07M | 3.61% | 3,736 | - |
| 496 | TVRD | Tvardi Therapeutics, Inc. | 10.78M | 0.37% | 72,046 | - |
| 497 | INTS | Intensity Therapeutics, Inc. | 10.58M | -5.54% | 3,097 | - |
| 498 | PTN | Palatin Technologies, Inc. | 10.49M | 7.31% | 16,696 | 13.19M |
| 499 | ICU | SeaStar Medical Holding Corporation | 10.47M | -9.13% | 2,109,368 | 1.71M |
| 500 | PHIO | Phio Pharmaceuticals Corp. | 10.45M | 2.22% | 17,412 | - |